Fifth Third Bancorp

SEC CIK: 0000035527
Latest filing: Aug 5, 2026

SEC filings (opens in a new tab)

EGRX holding history

Eagle Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EGRX overview All 13F holders of EGRX Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2022

Holdings of EGRX by Fifth Third Bancorp, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−43−100.0%	Sold out	Holders
Q2 2023	43	$836	<0.1%	+43	New	Holders
Q1 2023	0	$0	0.0%	−25−100.0%	Sold out	Holders
Q4 2022	25	$731	<0.1%	00.0%	Unchanged	Holders
Q3 2022	25	$1.00K	<0.1%	+25	New	Holders